Sunovion Pharmaceuticals is divesting its allergy and asthma products to focus more heavily on its products that treat chronic obstructive pulmonary disease.
ReWalk Robotics, a manufacturer of systems to help those with spinal chord and similar injuries, has signed an agreement for exclusive distribution with a French health provider.
Avecia, a pharmaceutical manufacturer in Milford, says it is building what will become the largest manufacturing site in the world for a specialized drug ingredient called oligonucleotide.
Roche Diagnostics will stop manufacturing in Marlborough by the fourth quarter and move production to other facilities in Europe and the U.S., the company confirmed Wednesday.